AspyreRx (Better Therapeutics Inc.) is a prescription-only digital therapeutic device intended to provide cognitive behavioral therapy to patients 18 years or older with type 2 diabetes (T2D). The device targets behavior to aid in the management of T2D in patients who are under the care of a healthcare provider. AspyreRx provides cognitive behavioral therapy as a treatment that should be used adjunctively with standard of care.
If you have a Hayes login, click here to view the full report on the Knowledge Center.